CIM LLC’s Amedisys AMED Stock Holding History

CIM LLC’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,004	Closed	-$300K	–	161
2020 Q4	$300K	Hold	1,004	–	–	0.06%	121
2020 Q3	$265K	Buy	+1,004	New	+$228K	0.05%	122
2018 Q4	–	Sell	-1,971	Closed	-$246K	–	98
2018 Q3	$246K	Buy	+1,971	New	+$218K	0.09%	102

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CIM LLC's AMED Position: Q1 2021 in Review

CIM LLC sold out of Amedisys (AMED) in Q1 2021, closing a stake of 1,004 shares — an estimated $300K sold.

CIM LLC first reported a position in AMED in Q3 2018 and held it in 3 quarters. The position peaked at $300K in Q4 2020. 388 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

CIM LLC reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
CIM LLC sold 1,004 Amedisys shares in Q1 2021, an estimated $300K.
CIM LLC first reported a position in Amedisys in Q3 2018 and held it in 3 quarters.
CIM LLC's Amedisys position peaked at $300K in Q4 2020.
388 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on CIM LLC's 13F filing for Q1 2021, filed 11 May 2021.